Techno Blender
Digitally Yours.
Browsing Tag

Biotechnology Services

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the…

Illumina Fined More Than $400 Million in Europe for Closing Grail Deal Early

The European Union’s antitrust watchdog fined the company with the maximum allowable amount for wrapping up its acquisition of the cancer-test developer while the agency was still reviewing it. The European Union’s antitrust watchdog fined the company with the maximum allowable amount for wrapping up its acquisition of the cancer-test developer while the agency was still reviewing it. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the…

FDA's OK Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful…

The Accountant Shortage Is Showing Up in Financial Statements

Advance Auto Parts and others have cited a lack of skilled accounting personnel for material weaknesses in their financial-reporting controls, a key predictor of restatements. Advance Auto Parts and others have cited a lack of skilled accounting personnel for material weaknesses in their financial-reporting controls, a key predictor of restatements. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content,…

New Gene Therapy Could Face Uphill Battle

The potential FDA approval of BioMarin’s gene therapy for hemophilia would be a major win, but patient uptake could be slow. The potential FDA approval of BioMarin’s gene therapy for hemophilia would be a major win, but patient uptake could be slow. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all…

Ecstasy-for-Medicine Advocate Looks for Cash Lifeline

MAPS, a nonprofit, is working on an $85 million private share sale to keep itself afloat until mid-2024, when it hopes to start selling MDMA in the U.S. MAPS, a nonprofit, is working on an $85 million private share sale to keep itself afloat until mid-2024, when it hopes to start selling MDMA in the U.S. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is…

The Price of First Gene Therapy for Muscular Dystrophy: $3.2 Million

The drug, from Sarepta Therapeutics, promises to repair the defective gene at the root of the fatal disorder, but is expected to cost millions of dollars. The drug, from Sarepta Therapeutics, promises to repair the defective gene at the root of the fatal disorder, but is expected to cost millions of dollars. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is…

Alzheimer's Blockbuster Is Coming, but Slowly

Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients. Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the…

After Illumina CEO’s Fall, Other Executives Are Expected to Take Hard Look at Deals

ShareListen(2 min) ShareListen(2 min) FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Illumina CEO Francis deSouza Resigns

Head of gene-sequencing test maker steps aside after regulators challenged deal for a cancer test-developer. Head of gene-sequencing test maker steps aside after regulators challenged deal for a cancer test-developer. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If…